STAT

Sepsis is the third leading cause of death. Can a new blood test change that?

Sepsis kills over 250,000 people a year in the United States — more than any cause other than cancer and heart disease. Can a blood test change that?

In his spare time, when he feels up to it, Ronnie Roberts walks through hospital parking lots slipping informational flyers onto every windshield.

Roberts wants people to know the signs of sepsis, the body’s overwhelming response to a blood infection, which can lead to organ failure and even death. If he had known the signs and insisted that his fiancee was treated appropriately, he believes she’d still be alive.

Sepsis kills over 250,000 people a year in the United States — more than any cause other than cancer and heart disease. But still, many people have never heard of it. And hospitals often fail to notice the warning signs when a patient is spiraling downward.

It’s a complex condition, and researchers are pursuing various avenues to reduce deaths. Last month, for instance, the Food and Drug Administration

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks